Vaginal self-sampling for HPV in the context of cervical cancer screening

Lauma Spriņģe (Corresponding Author), Anda Ķīvīte-Urtāne, Elita Poplavska, Jana Žodžika, Natālija Bērza, Aija Bukova-Žideļūna, Alise Čurkste, Kersti Parna, Anneli Uuskula

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Background
Effective cervical cancer screening programme has the potential to improve disease outcomes, yet women’s participation rates in Latvia remain suboptimal. Utilizing vaginal self-sampling for HPV, a convenient method, has demonstrated efficacy in boosting participation in under-screened populations. We analysed sociodemographic factors, as well as health behaviours with the preference for vaginal self-sampling procedures for early detection of cervical cancer.

Methods
Cross-sectional survey (2021-2022) included 1313 women in Latvia. Sampling was done in the colposcopy clinic and among GP practices. In the univariate analysis cervical cancer examination preference (self-test or by a physician) was analysed in association sociodemographic factors, participation in the screening, HPV status, study group, and health-related behaviour. Financed by “Internal consolidation of RSU and external consolidation of RSU with LSPA” (No. 5.2.1.1.i.0/2/24/I/CFLA/005), The EU Recovery and Resilience plan and the state budget, Grant Nr. RSU-PAG-2024/1-0016.

Results
48.6 % (n = 538) of the women would prefer to use a vaginal self-test. Higher odds of the vaginal self-test preference were observed among Latvian (OR = 1.4 (1.1-1.8) vs other nationality women, but no other sociodemographic factors showed statistically significant associations. Women in the colposcopy study group (vs GP practices) were more likely to utilize self-sampling (OR = 1.8 (1.4-2.5). Non-participation in cervical cancer screening was related to 2.4 (1.6-3.6) higher odds of self-test preference, but knowledge about screening was related to 1.5 (1.1-2.0) times higher odds. Women who were HPV-negative were more likely to prefer vaginal self-test for HPV (OR = 1.4 (1.1-1.8) in comparison to HPV-positive women. Health-related behaviour did not show any associations.

Conclusions
Vaginal self-test for HPV can be effectively used to reach under-screened populations and enhance cervical cancer screening coverage.

Key messages
• The implementation of vaginal self-sampling for HPV testing has the potential to improve participation rates in cervical cancer screening programs among under-screened populations.
• Outreach and education activities tailored to specific target groups in population could enhance level of the cervical cancer screening uptake.
Original languageEnglish
Article numberckae144.707
JournalEuropean Journal of Public Health
Volume34
Issue numberSuppl.3
DOIs
Publication statusPublished - 28 Oct 2024
Event17th European Public Health Conference 2024 : "Sailing the Waves of European Public Health: Exploring a Sea of Innovation" - Lisbon, Portugal
Duration: 12 Nov 202415 Nov 2024

Keywords*

  • cervical cancer
  • Cervical cancer screening

Field of Science*

  • 3.3 Health sciences
  • 3.2 Clinical medicine

Publication Type*

  • 3.4. Other publications in conference proceedings (including local)

Fingerprint

Dive into the research topics of 'Vaginal self-sampling for HPV in the context of cervical cancer screening'. Together they form a unique fingerprint.

Cite this